178 related articles for article (PubMed ID: 27721090)
1. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
[TBL] [Abstract][Full Text] [Related]
2. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
4. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
Granata V; Fusco R; Catalano O; Filice S; Amato DM; Nasti G; Avallone A; Izzo F; Petrillo A
PLoS One; 2015; 10(11):e0142876. PubMed ID: 26566221
[TBL] [Abstract][Full Text] [Related]
5. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
[TBL] [Abstract][Full Text] [Related]
6. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
7. Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
Liu LH; Zhou GF; Lv H; Wang ZC; Rao SX; Zeng MS
Eur Radiol; 2021 Aug; 31(8):5640-5649. PubMed ID: 33449175
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Early Response to Chemotherapy in Breast Cancer Liver Metastases by Diffusion-Weighted MR Imaging.
Bai G; Wang Y; Zhu Y; Guo L
Technol Cancer Res Treat; 2019 Jan; 18():1533033819842944. PubMed ID: 30961445
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
10. Intravoxel Incoherent Motion of Colon Cancer Liver Metastases for the Assessment of Response to Antiangiogenic Treatment: Results from a Pilot Study.
Öz A; Server S; Koyuncu Sökmen B; Namal E; İnan N; Balcı NC
Med Princ Pract; 2020; 29(5):429-435. PubMed ID: 31914438
[TBL] [Abstract][Full Text] [Related]
11. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
[TBL] [Abstract][Full Text] [Related]
12. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
[TBL] [Abstract][Full Text] [Related]
13. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy.
Zhu HB; Xu D; Zhang XY; Li XT; Xing BC; Sun YS
Ann Surg Oncol; 2022 Jun; 29(6):3938-3949. PubMed ID: 35013857
[TBL] [Abstract][Full Text] [Related]
15. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.
Ravanelli M; Agazzi GM; Tononcelli E; Roca E; Cabassa P; Baiocchi G; Berruti A; Maroldi R; Farina D
Radiol Med; 2019 Sep; 124(9):877-886. PubMed ID: 31172448
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.
Zhang H; Li W; Fu C; Grimm R; Chen Z; Zhang W; Qiu L; Wang C; Zhang X; Yue L; Hu X; Guo W; Tong T
Eur J Radiol; 2020 Sep; 130():109149. PubMed ID: 32659615
[TBL] [Abstract][Full Text] [Related]
17. Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.
Zheng DX; Meng SC; Liu QJ; Li CT; Shang XD; Zhu YS; Bai TJ; Xu SM
World J Gastroenterol; 2016 Mar; 22(10):3031-7. PubMed ID: 26973399
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
